Dr. Harbison has had 20 years experience in drug and companion diagnostics development at Roche with particular expertise in project leadership, clinical strategy, regulatory strategies, and preclinical drug development. Most recently, as Vice President at Roche Molecular Diagnostics she was responsible for development of the Genomics and Oncology portfolio of molecular biomarker and companion diagnostics. Prior to that, Dr. Harbison held global project leadership positions in the Pharma division leading cross-functional lifecycle teams for drugs in development. These included small molecules and biologics in a variety of therapeutic areas. Dr. Harbison also served as Global Head of project management. Earlier at Roche. Dr. Harbison built her career in pathology and toxicology. She is a board-certified veterinary pathologist and holds a B.A. and a Doctorate of Veterinary Medicine (V.M.D) from the University of Pennsylvania. Her pathology training was carried out at Harvard Medical School under a National Institutions of Health post-doctoral fellowship.

 pathology toxicology